DENTAID SL
πͺπΈSpain
Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)
Not Applicable
Completed
- Conditions
- Viral Pharyngitis
- Interventions
- Drug: CPC mouthwashDrug: Placebo
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Dentaid SL
- Target Recruit Count
- 102
- Registration Number
- NCT06251089
- Locations
- πͺπΈ
EAP Baix Llobregat, Barcelona, Spain
Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.
Not Applicable
Completed
- Conditions
- SARS-CoV-2 Infection
- Interventions
- Other: Distilled water with the same colorant as the experimental productOther: 0.07% cetylpyridinium chloride (CPC) in mouthwash
- First Posted Date
- 2021-02-17
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Dentaid SL
- Target Recruit Count
- 118
- Registration Number
- NCT04757818
- Locations
- πͺπΈ
CAP Fondo, Santa Coloma De Gramenet, Barcelona, Spain
πͺπΈCAP Gorg, Badalona, Barcelona, Spain
πͺπΈCAP Gran Sol, Badalona, Barcelona, Spain
Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients
Not Applicable
Completed
- Conditions
- Covid19
- Interventions
- Other: placebo rinseOther: CHX0.12+CPC0.05 oral rinse (PerioAidActive Control)
- First Posted Date
- 2020-09-24
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Dentaid SL
- Target Recruit Count
- 23
- Registration Number
- NCT04563689
- Locations
- π¨π΄
Escuela odontologia. Facultad de Salud Hospital del Valle, Cali, Colombia
Β© Copyright 2025. All Rights Reserved by MedPath